Samardzic, Jure <br/><br/>
Impact of Continuous P2Y12 Inhibition Tailoring in Acute Coronary Syndrome and Genetically Impaired Clopidogrel Absorption.  [electronic resource] 

 -  Journal of cardiovascular pharmacology  02 2020 
 - 174-179 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4023 
<br/><br/><label>Standard No.: </label>10.1097/FJC.0000000000000767  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B--genetics<br/>Acute Coronary Syndrome--blood<br/>Aged<br/>Blood Platelets--drug effects<br/>Clopidogrel--administration & dosage<br/>Drug Monitoring<br/>Female<br/>Gastrointestinal Absorption--genetics<br/>Humans<br/>Male<br/>Middle Aged<br/>Pharmacogenomic Variants<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Purinergic P2Y Receptor Antagonists--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Receptors, Purinergic P2Y12--blood<br/>Treatment Outcome